Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106645183 | 10664518 | 3 | F | 201008 | 20160912 | 20141219 | 20160916 | EXP | FR-009507513-1102FRA00105 | MERCK | 79.00 | YR | F | Y | 0.00000 | 20160916 | CN | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106645183 | 10664518 | 1 | PS | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | Oral | 100 MG, QD | Y | 21995 | 100 | MG | FILM-COATED TABLET | QD | |||||
| 106645183 | 10664518 | 2 | C | OROCAL D3 | CALCIUM CARBONATECHOLECALCIFEROL | 1 | Oral | U | 0 | TABLET | |||||||||
| 106645183 | 10664518 | 3 | C | DIFFU-K | POTASSIUM CHLORIDE | 1 | Oral | 0 | TABLET | ||||||||||
| 106645183 | 10664518 | 4 | C | KERLONE | BETAXOLOL HYDROCHLORIDE | 1 | Oral | UNK MG, UNK | 0 | TABLET | |||||||||
| 106645183 | 10664518 | 5 | C | ESIDREX | HYDROCHLOROTHIAZIDE | 1 | Oral | UNK MG, UNK | 0 | TABLET | |||||||||
| 106645183 | 10664518 | 6 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | Oral | UNK MG, UNK | 0 | TABLET | |||||||||
| 106645183 | 10664518 | 7 | C | ARESTAL | LOPERAMIDE OXIDE | 1 | Oral | 0 | TABLET | ||||||||||
| 106645183 | 10664518 | 8 | C | ATARAX | HYDROXYZINEHYDROXYZINE HYDROCHLORIDE | 1 | Oral | 0 | TABLET | ||||||||||
| 106645183 | 10664518 | 9 | C | LIORAM | 2 | Oral | 0 | TABLET | |||||||||||
| 106645183 | 10664518 | 10 | C | ELISOR | PRAVASTATIN SODIUM | 1 | Oral | UNK MG, UNK | U | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 106645183 | 10664518 | 1 | Type 2 diabetes mellitus |
| 106645183 | 10664518 | 4 | Hypertension |
| 106645183 | 10664518 | 5 | Hypertension |
| 106645183 | 10664518 | 6 | Gastrooesophageal reflux disease |
| 106645183 | 10664518 | 10 | Dyslipidaemia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 106645183 | 10664518 | HO |
| 106645183 | 10664518 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 106645183 | 10664518 | Pemphigoid | |
| 106645183 | 10664518 | Pruritus | |
| 106645183 | 10664518 | Urticaria |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 106645183 | 10664518 | 1 | 20100709 | 20110124 | 0 |